Journal of the American Medical Directors Association
Special ArticleAsian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Section snippets
Consensus Process
AWGS founding members (L. K. Chen, H. Arai, J. Woo, C. W. Won, and P. Assantachai) used PubMed searches to identify other researchers with pertinent expertise from Asian countries or regions, whom they invited to lead special interest groups on the topics of epidemiology, case-finding, diagnosis, muscle mass, muscle strength, physical performance, and treatment. Group leaders were appointed at face-to-face meetings in Nagoya, Japan, and tasked to recruit members to help them source and appraise
Definition of Sarcopenia
The definition and diagnosis of sarcopenia are still evolving as new findings challenge current understanding. Nevertheless, given limited Asian data and controversy about using the term sarcopenia where muscle wasting may predominantly be due to coexisting conditions such as cachexia or paralysis, the AWGS decided against following a recent trend to consider all muscle wasting as sarcopenia and therefore retains its original definition of “age-related loss of skeletal muscle mass plus loss of
Epidemiology
The review of epidemiology studies from Asian countries that used AWGS 2014 criteria discovered that the prevalence of sarcopenia ranged from 5.5% to 25.7%, with male predominance (5.1%-21.0% in men vs 4.1%-16.3% in women) (Supplementary Table 1)12, 13, 14,S1, S2, S3, S4, S5, S6, S7, S8, S9, S10; the prevalence became more consistent—7.3% to 12.0%—if only studies with more than 1000 male and female participants were included.12, 13, 14,S9 Older age may be the most important among numerous
Diagnosis of Sarcopenia
Figure 1 shows the AWGS 2019 algorithm for identifying and diagnosing older adults with or at-risk for sarcopenia, including case-finding, assessment, and diagnostic protocols for use in either hospital and research settings, or in community-based health care and screening.
The special interest group review of sarcopenia diagnosis discovered that most studies done in Asian countries had used the AWGS 2014 criteria. Following extensive deliberations, AWGS 2019 contends that diagnosing sarcopenia
Case-finding
The case-finding special interest group reviewed studies from East and Southeast Asia that used screening or assessment instruments to identify early signs of sarcopenia. Based on related validation reports, AWGS 2019 recommends using either calf circumference (CC) or the SARC-F or SARC-CalF questionnaires for case-finding.
The recommended protocol for CC measures the maximum value of both calves using a nonelastic tape, which has moderate-to-high sensitivity and specificity in predicting
Skeletal Muscle Mass Measurement
The special interest group review on muscle mass measurement focused on techniques, body-size adjustment methods, and determining cutoff values. Although magnetic resonance imaging, computed tomography, dual-energy X-ray absorptiometry (DXA), and BIA have all been used to estimate skeletal muscle mass, DXA and BIA were the most commonly used modalities in Asia, and the AWGS 2014 cutoffs were widely adopted. BIA measurement with a multifrequency device correlated more closely with DXA-measured
Muscle Strength
Almost all studies in East and Southeast Asia that focused on muscle strength, function, and sarcopenia had used handgrip strength to indicate skeletal muscle strength; therefore, AWGS 2019 retains the recommendation to use handgrip strength. Although handgrip strength was widely used, measurement protocols varied between studies. The devices used most often in Asia are the spring-type dynamometer (Smedley), followed by hydraulic-type (Jamar);42 AWGS 2019 recommends using either device to
Physical Performance
Published research used a wide range of physical performance tests, including the Short Physical Performance Battery (SPPB), usual gait speed, 6-minute walk test, stair-climb power test, timed-up-and-go test, and 5-time chair stand test.4, 5, 6 Usual gait speed was the most frequently used test and was strongly associated with the onset of disability, severe mobility limitation, and mortality (Table 2).23, 24, 25,33,46, 47, 48,S3, S5, S13, S25, S26, S27, S28, S29,S35, S36, S37, S39, S40, S41,
Treatment and Intervention
A systematic review of randomized controlled trials (RCTs) through 2016 examined the effects of exercise, nutrition, combined exercise and nutrition, and pharmacologic agents on sarcopenia.9 For people with sarcopenia as defined by EWGSOP 2010, AWGS 2014, or combined muscle mass and function and/or strength, exercise alone effectively increased ASM and gait speed. Meta-analysis of 12 RCTs (not exclusively using AWGS 2014 or EWGSOP 2010 criteria) showed variable effects of nutrition alone on
Implications for Practice, Policy, and Research
AWGS 2019 highlights the impact of sarcopenia in all health care settings and recommends individualized lifestyle intervention that may be implemented across the health care spectrum. To promote healthy aging, AWGS 2019 has defined a new entity of “possible sarcopenia” to facilitate timely lifestyle intervention in community health care and prevention settings, which will contribute to higher awareness of sarcopenia prevention and interventions in diverse health care settings. However, more
Acknowledgments
Dr David Neil, of Full Universe Integrated Marketing, Taipei, Taiwan, provided editorial assistance and his colleague Pei Chi Kuo assisted with manuscript preparation and project management; Taipei Veterans General Hospital and Ministry of Science and Technology, Taiwan (MOST-107-2634-F-010-001) supported these contributions.
References (61)
- et al.
Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia
J Am Med Dir Assoc
(2011) - et al.
Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia
J Am Med Dir Assoc
(2014) - et al.
Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia
J Am Med Dir Assoc
(2016) - et al.
Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: Results from the Osteoporotic Fractures in Men (MrOs) Study
J Am Med Dir Assoc
(2014) - et al.
Defining sarcopenia in terms of incident adverse outcomes
J Am Med Dir Assoc
(2015) - et al.
Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men
J Am Med Dir Assoc
(2014) - et al.
Calf circumference as a screening instrument for appendicular muscle mass measurement
J Am Med Dir Assoc
(2018) - et al.
A simple questionnaire to rapidly diagnose sarcopenia
J Am Med Dir Assoc
(2013) - et al.
Validation of the Korean version of the SARC-F questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study
J Am Med Dir Assoc
(2018) - et al.
Comparing Mini Sarcopenia Risk Assessment with SARC-F for screening sarcopenia in community-dwelling older adults
J Am Med Dir Assoc
(2019)
SARC-F for screening of sarcopenia among older adults: A meta-analysis of screening test accuracy
J Am Med Dir Assoc
Validating the SARC-F: A suitable community screening tool for sarcopenia?
J Am Med Dir Assoc
Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality
J Am Med Dir Assoc
J Am Med Dir Assoc
Modulating effect of contextual factors on factor structure and reliability of SARC-F
J Am Med Dir Assoc
A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people
J Nutr Health Aging
Screening for frailty and sarcopenia among older persons in medical outpatient clinics and its associations with healthcare burden
J Am Med Dir Assoc
Utility of SARC-F for assessing physical function in elderly patients with cardiovascular disease
J Am Med Dir Assoc
Letter to the editor: Case for validated instead of standard cut-offs for SARC-CalF
J Nutr Health Aging
Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people
BMC Geriatr
Normative data of handgrip strength in 26344 older adults – a pooled dataset from eight cohorts in Asia
J Nutr Health Aging
Association between speed of sound of calcaneal bone assessed by quantitative ultrasound and sarcopenia in a general older adult population: A cross-sectional study
J Orthop Sci
Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study
J Geriatr Oncol
Gait performance trajectories and incident disabling dementia among community-dwelling older Japanese
J Am Med Dir Assoc
Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia: A randomized controlled trial
Nutrition
Sarcopenia: Burden and challenges for public health
Arch Public Health
Sarcopenia and its implications for metabolic health
J Obes
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
Age Ageing
Chapter 1: Definitions and diagnosis of sarcopenia
Geriatr Gerontol Int
Sarcopenia: Revised European consensus on definition and diagnosis
Age Ageing
Cited by (2818)
Association of sarcopenia with osteoporosis in Chinese patients with type 2 diabetes
2024, BMC Musculoskeletal DisordersThe prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis
2024, Arthritis Research and Therapy
This research was supported by funding from the National Center for Geriatrics and Gerontology (NCGG), Research Funding for Longevity Sciences (28-30) Japan, the Hong Kong Geriatrics Society (HKGS) and the Taiwan Association of Integrated Care (TAIC). The NCGG, HKGS, and TAIC were not involved in designing the study, nor subject recruitment, acquiring or analyzing data, or preparing the article.
The authors declare no conflicts of interest.